Huggins v. Stryker Corp., 932 F. Supp. 2d 972

Huggins sues Stryker for injuries from intra-articular pain pumps allegedly causing shoulder chondrolysis after February 2002 surgery.
Stryker moved to transfer venue to the District of Oregon, and moved for summary judgment and to exclude certain expert testimony.
Huggins’ first surgery occurred in Oregon; case was filed in Minnesota; Minnesota statutes of limitations and tolling play a central role.
Evidence includes FDA 510(k) history, pre-2002 literature, and internal marketing/testing concerns surrounding intra-articular pump use.
Court denied transfer, denied summary judgment on causation and foreseeability issues, and denied motions to exclude expert testimony.
The case is set for the court’s next available trial calendar.

Issue	Plaintiff's Argument	Defendant's Argument	Held
Whether to grant transfer under § 1404(a).	Huggins argues transfer to Oregon is warranted for convenience and justice.	Stryker argues transfer is warranted due to forum considerations.	Transfer denied; factors favor denial.
Whether Huggins' claims are time-barred by Minnesota's statute of limitations.	Discovery rule tolls accrual until causal connection evidence exists.	Accrual occurred earlier; statute of limitations expired.	Not time-barred; discovery rule adopted for accrual.
Whether Stryker owed a duty to warn about intra-articular pain pump risks.	Manufacturer should warn when it could discover risks; literature and testing support warning.	Foreseeability of specific chondrolysis risk was not established.	Jury could find foreseeability; duty to warn exists.
Whether expert testimony on literature, testing, and causation should be excluded under Daubert.	Experts’ methodologies and conclusions are reliable and relevant.	Experts misinterpret literature and rely on hindsight; reliability questionable.	Experts’ testimony admitted; Daubert challenges denied.

Hildebrandt v. Allied Corp., 839 F.2d 396 (8th Cir.1987) (discovery rule applicable to product-liability accrual)
Dalton v. Dow Chem. Co., 158 N.W.2d 584 (Minn. 1968) (evidence of causation can affect accrual in products cases)
Domagala v. Rolland, 805 N.W.2d 14 (Minn.2011) (foreseeability standard for duty to warn; jury question in close cases)
O’Hare v. Merck & Co., 381 F.2d 286 (8th Cir.1967) (duty to warn depends on knowledge and reasonable care)
Kociemba v. G.D. Searle & Co., 707 F. Supp. 1517 (D. Minn. 1989) (duty to test and keep informed as part of warning duties)
Daubert v. Merrell Dow Pharm., Inc., 509 U.S. 579 (S. Ct. 1993) (reliability standard for expert testimony)
Rodriguez v. Stryker Corp., 680 F.3d 568 (6th Cir.2012) (foreseeability and warning duties in pain-pump context vary by circuit)
Mack v. Stryker Corp., 893 F. Supp. 2d 976 (D. Minn. 2012) (district court recognizing discovery-rule approach to accrual in pain-pump cases)
Buckman Co. v. Plaintiffs' Legal Comm., 531 U.S. 341 (U.S. 2001) (preemption concerns in federal-law claims overlapping with state tort duties)